Jiangsu Bojun Industrial Technology Co., Ltd. 2025 Annual Independent Director Performance Report (Gao Fang)
As an independent director of Jiangsu Bojun Industrial Technology Co., Ltd. (hereinafter referred to as the "Company"), I have strictly adhered to the "Company Law," "Securities Law," "Administrative Measures for Independent Directors of Listed Companies," "Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 2 - Norms for Operation of GEM Listed Companies," and other laws, regulations, and the "Articles of Association" and "Work System for Independent Directors." During my work in 2025, I diligently performed my duties as an independent director, actively attended relevant meetings, participated in the decision-making of major company matters, and provided independent and objective opinions on matters reviewed by the board of directors, effectively safeguarding the overall interests of the company and the legitimate rights and interests of all shareholders, especially small and medium investors. Herein is my report on the performance of my duties as an independent director in 2025:
I. Basic Information
(I) Personal Work Experience, Professional Background, and Concurrent Positions
Ms. Gao Fang, born in 1980, is a Chinese national with no permanent overseas residency. She holds a Ph.D. in Accounting and is an associate professor and master's supervisor. From August 2007 to August 2014, she served as a lecturer and master's supervisor at the School of Management, Ocean University of China. From September 2014 to present, she has been an associate professor and master's supervisor at the School of Business Administration, Donghua University. From May 2024 to present, she has served as an independent director of Wuhu Fucai Technology Co., Ltd. From November 2024 to present, she has served as an independent director of Jiangsu Hengshen Co., Ltd. From December 2024 to present, she has served as an independent director of the Company. From September 2025 to present, she has served as an independent director of Sansheng Guojian Pharmaceutical (Shanghai) Co., Ltd.
(II) Explanation of Circumstances Affecting Independence
During my tenure as an independent director of the Company, I have not held any positions in the Company other than that of an independent director, nor have I held any positions in the major shareholders of the Company. There are no relationships between myself and the Company or its major shareholders that would hinder my independent and objective judgment, and there are no circumstances affecting my independence.
II. Annual Performance
(I) Meeting Attendance
In 2025, during my term of office, the Company held 14 board meetings and 2 shareholder meetings. As an independent director of the Company, I personally attended all board and shareholder meetings held during my term, diligently performed my duties as an independent director and exercised my voting rights, without absence, entrusting others to attend, or failing to attend in person for two consecutive meetings.
| Attendance for Board Meetings | Personal Attendance (times) | Entrusted Attendance (times) | Absence (times) | Annual Attendance for Shareholder Meetings | Attendance (times) | Non-Attendance (times) |
|---|---|---|---|---|---|---|
| 14 | 14 | 0 | 0 | 2 | 2 | 0 |
In 2025, during my term of office, the convening and holding of the Company's board meetings all complied with legal procedures. Major operational decision-making matters and other significant matters underwent the relevant approval procedures, which were legal and effective. I carefully reviewed all proposals submitted for deliberation at the meetings, actively participated in discussions on various agenda items, and offered rational suggestions. I exercised my voting rights with a rigorous attitude. In 2025, I did not raise any objections to any proposals and voted in favor of all relevant proposals.
I believe that the major matters deliberated by the Company in 2025 comply with the "Company Law," "Guidelines for Corporate Governance of Listed Companies," and the "Articles of Association," embodying the principles of openness, fairness, and justice. The deliberation and voting procedures were legal and effective, and there were no circumstances that harmed the interests of the Company and its shareholders, especially small and medium investors.